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Obesity is a negative predictor of success after
surgery for complex anal fistula
O Schwandner
Abstract
Background: It was the aim of this study to compare the outcome of surgery for complex anal fistulas in obese
and non-obese patients.
Methods: All patients with complex anorectal fistulas who underwent fistulectomy and/or rectal advancement flap
repair were prospectively recorded. Surgery was performed in a standardized technique. Body mass index (BMI [kg/
m
2]) was used as objective measure to indicate morbid obesity. Patients with a BMI greater than 30 were defined
as obese, and patients with a BMI below 30 were defined as non-obese. The parameters analyzed related to BMI
included success or failure, and reoperation rate due to recurrent abscess. Success was defined as closure of both
internal and external openings, absence of drainage without further intervention, and absence of abscess
formation.
Results: Within two years, 220 patients underwent advancement flap repair and met the inclusion criteria. 55% of
patients were females, mean age was 39 (range 18-76) years, and the majority of fistulas were located at the
posterior site. 69% of patients (152/220) were non-obese (BMI < 30), whereas 31% (68/220) were obese (BMI > 30).
After a median follow-up of 6 months, primary healing rate ("success”) for the whole collective was 82% (180/220).
Success was significantly different between non-obese and obese patients: In non-obese patients, recurrence rate
was significantly lower than in obese patients (14% vs. 28%; p < 0.01). Moreover, reoperation rate due to recurrent
abscess with the need for seton drainage in the failure groups was significantly higher in obese patients when
compared to non-obese patients (73% vs. 52%; p < 0.01). Using multivariate analysis, obesity was identified as
independent predictive factor of success or failure (p < 0.02).
Conclusion: Obese patients are at higher risk for failure after surgery for complex anal fistula.
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Background
T h em a i ni s s u eo fs u r g e r yf o ra n a lf i s t u l a si st op r o v i d e
definite healing and to prevent incontinence. Focussing
on complex anal fistulas, it can be stated that rectal
advancement flap repair represents an effective treat-
ment option [1,2]. To date, neither the addition of fibrin
glue or local administration of antibiotics nor the use of
bioprosthetic plugs did improve healing rates when
compared to advancement flap repair alone [2-8]. The
main advantages of the advancement flap repair are that
it is repeatable, and that the flap procedure can be com-
bined with sphincter reconstruction in anterior fistula
which has a tremendous impact on continence especially
in females. However, although the sphincter muscle is
not divided during the flap repair, minor impairement
of continence has been reported in up to a third and
major incontinence in approximately 5-10% of patients.
Additionally, looking for predictors of success or failure,
undrained perianal sepsis, complexity of fistula, missing
identification of the internal opening, number of pre-
vious attempts to close the fistula, Crohn’s disease, rec-
tovaginal fistula, and previous radiation therapy have
been shown to deteriorate primary success rates [2].
At present, obesity is one of the most important
health problem and it is known to aggravate numerous
health disorders such as cardiovascular disease, hyper-
tension, and metabolic disorders. Focussing on the
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patients are generally believed to be at increased risk for
surgery or adverse outcomes than those who are not
obese [9]. However, to date, there is no information
available, whether obesity represents a factor predictive
of failure or recurrence following definite surgery for
anal fistula of cryptoglandular origin. Therefore, it was
the aim of this prospective study to compare the out-
come of fistulectomy and rectal advancement flap repair
for complex anal fistulas in obese and non-obese
patients.
Methods
Study design
For the current study, the body mass index (BMI [kg/
m
2]) was used as objective measure to indicate morbid
obesity because it fulfils the mandatory criteria for an
epidemiological index of obesity [9]. Patients with a
BMI greater than 30 (> or = 30) were defined as obese,
and patients with a BMI below 30 (<30) were defined as
non-obese.
All patients with complex anal fistulas who underwent
ad e f i n i t es u r g i c a lc l o s u r ep e r f o r m e db yo n es u r g e o n
(fistulectomy, rectal advancement flap repair) were pro-
spectively enrolled, and data were retrospectively ana-
lyzed in relation to obesity. The study was conducted at
the Caritas-Krankenhaus St. Josef Regensburg. As the
study was conducted as a retrospective observational
outcome analysis without any experimental research,
ethical commitee approval was not necessary. Inclusion
criteria included supra-, trans- or intersphincteric fistu-
las of cryptoglandular origin according to Parks classifi-
cation [10]. To provide a homogenous patient collective,
rectovaginal and Crohn’s associated anal fistula as well
as patients with fecal diversion were excluded from ana-
lysis. Furthermore, patients in which the internal open-
ing could not be identified during primary surgery were
excluded (Table 1).
Primary end-points of this study included success or
failure related to body status. Success was defined as
closure of both internal and external openings, absence
of drainage without further intervention, and absence of
abscess formation. Additionally, morbidity and reopera-
tion rate for abscess recurrence were analyzed. In all
patients, informed consent was obtained. The study was
self-funded, and no financial support was received.
Surgical Technique
All patients were examined preoperatively in the procto-
logical office to exclude residual anorectal abscess.
Patients who had seton drainage due to previous drai-
nage of concomitant abscess were examined with endoa-
nal ultrasound. MRI was not used routinely. Focussing
on surgical strategy, patients who had seton drainage
were scheduled for definite surgery after a time interval
of 6-8 weeks. In addition to fistulectomy, fistulas in
which the fistula tract was located in the upper two-
thirds of the external sphincter were treated by rectal
advancement flap repair. On the day of surgery, bowel
preparation was performed by enema, no patient under-
went mechanical bowel preparation. A single-dose anti-
biotic prophylaxis (cefotaxime and metronidazole) was
mandatory. Procedures were either performed under
general or spinal anesthesia (according to patients’ pre-
ference) and in lithotomy position.
All fistula tracts (including internal and external open-
ing) were identified with a conventional fistula probe in
all patients (with or without a seton drainage) to define
the type of fistula according to the Parks classification
[10]. After replacement of the seton drainage, the fistula
tract was irrigated with antiseptic polyhexanide solution
(Lavanid
®1; Serag Wiessner, Naila/Bayern, Germany). It
was crucial to excise the fistula tract running from the
external opening to the external anal sphincter and to
have a sufficient external drainage wound. Using a Parks
or Simms retractor, a full-thickness flap consisting of
mucosa, submucosa, and the internal sphincter was
mobilized from the level of the dentate line to 2-6 cm
cephalad. The base of the flap was approximately twice
the width of its apex. The crypt-bearing tissue around
the internal opening was excised, and the fistula tract
was cored out of the sphincters. The defect of the inter-
n a la n a ls p h i n c t e rw a sc l o s e dw i t ha b s o r b a b l es u t u r e s
(Vicryl 2/0
®, Ethicon Endo-Surgery, Norderstedt, Ger-
many). After excision of its apex, the full-thickness flap
is advanced and sutured without any tension to the
“neodentate line” or to the subcutaneous parts of the
external sphincter where appropriate using absorbable
sutures (Vicryl 3/0
®, Ethicon Endo-Surgery, Norderstedt,
Germany).
Postoperatively, immediate feeding (regular food) was
administered, no further antibiotics were given. Patients
were discharged on the 1st postoperative day.
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Transsphincteric fistula of cryptoglandular origin Superficial fistulas amenable for fistulotomy
Suprasphincteric fistula of cryptoglandular origin Rectovaginal and fistulas associated to Crohn’s disease
High intersphincteric fistula of cryptoglandular origin Concomitant anorectal abscess or internal opening not identified
Seton drainage Fecal diversion
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All patients were followed up within 2-4 weeks after
surgery to monitor regular wound healing. Specific fol-
low-up information was derived from clinical examina-
tion 3 and 12 months postoperatively; moreover, time
intervals of patients with recurrence or failure were
registered. The follow-up was performed in an office
setting with regular clinical examination (including digi-
tal examination, proctoscopy, evaluation of the fistula
status by using a conventional fistula probe) and assess-
ment of success or failure. Follow-up examination was
performed by the operating surgeon (O.S.).
Statistical analysis
Statistics included both univariate and multivariate ana-
lysis for comparison of success rates using the SPSS
®
software package. Only factors which reached statistical
significance in univariate analysis were entered into
multivariate analysis. BMI was analyzed as a dichoto-
mous variable to provide sufficient patient numbers. Sta-
tistical significance was assessed at the 5% level (p <
0.05 statistically significant).
Results
Between September 2007 and September 2009, 220
patients were operated on for anal fistulas in the study
period and met the inclusion criteria. 55% of patients were
females, mean age was 39 (range 18-76) years, and the
majority of fistulas were located at the posterior site.
Details of patients’ demographics, fistulas, co-morbidities,
and type of surgery are summarized in Table 2. 69% of
patients (152/220) were non-obese (BMI < 30), whereas
31% (68/220) were obese (BMI > 30). The majority of
patients underwent rectal advancement flap repair,
whereas a minority had fistulectomy (Table 2). Postopera-
tive morbidity occurred in 6 patients (minor bleeding 1;
urinary tract infection 1; urinary retention 1; sphincter
spasm with pain 3) regardless of body-mass status. After a
median follow-up of 6 (range 3-18) months, primary heal-
ing rate ("success”) for the whole collective was 82% (180/
220). As outlined in Table 3, success was significantly dif-
ferent between non-obese and obese patients: In non-
obese patients, recurrence rate was significantly lower
(14%; 21/152) than in obese patients (28%; 19/68) (p <
0.01). Moreover, reoperation rate due to recurrent abscess
with the need for seton drainage in the failure groups was
significantly higher in obese patients when compared to
non-obese patients (73%; 14/19 vs. 52%; 11/21) (p < 0.01).
No other factor (age, tertiary referral, fistula location,
number of previous attempts to close the fistula, smoking,
diabetes, type of surgery) was associated with outcome.
Using multivariate regression analysis, obesity was identi-
fied as independent predictive factor of success or failure
(p < 0.02, multivariate hazard ratio 3.35).
Discussion
Objectively, there is only little evidence on the “optimal”
treatment for complex anal fistulas. A systematic review
published by Malik and Nelson identified 21 randomized
studies and 2 meta-analyses for evaluation [2]. The only
conclusions which could be derived from the literature
were that flap repair may not be worse than fistulotomy
related to healing rates, and that flap repair in combina-
tion with fibrin glue may increase failure rates [2]. Fol-
lowing this review, only 3 randomized studies were
available to assess the impact of rectal advancement flap
repair [11-13]. In general, two of these randomized
compared advancement flap repair with “conventional”
treatment (e.g. fistulotomy) [11,12], whereas Gustaffson
and colleagues examined whether the addition of an
antibiotic impregnated sponge would influence success
Table 2 Results: Patients’demographics, fistulas and
surgical data
Variable BMI < 30 BMI ≥ 30
No. of patients 152 68
Mean age (years) 39 (21-
76)
39 (18-
64)
Tertiary referral (%) 46 (30%) 22 (32%)
Previous fistula surgery prior to advancement
flap
0 118 (78%) 40 (58%)
1 12 (8%) 11 (16%)
2 10 (6%) 9 (13%)
3 or more 12 (8%) 8 (13%)
Fistula type
transsphincteric 96 (63%) 45 (66%)
intersphincteric 50 (33%) 19 (28%)
suprasphincteric 6 (4%) 4 (6%)
Fistula location
anterior 32 (21%) 10 (15%)
posterior 120 (79%) 58 (85%)
Horse-shoe-fistula (%) 6 (4%) 5 (7%)
Seton drainage (%) 132 (87%) 58 (85%)
Co-morbidity (cardiovascular, diabetes) 30 (20%) 30 (44%)
Co-morbidity (smoking) 50 (33%) 25 (37%)
Advancement flap repair (%) 108 (71%) 47 (69%)
Mean operative time (min) 20 (12-
32)
24 (18-
40)
Morbidity (%) 3 (2%) 3 (4%)
Table 3 Success and failure rates
Variable BMI < 30 BMI ≥ 30
Overall success rate 86% (131/152) 72% (49/68)
Overall failure rate 14% (21/152) 28% (19/68)
Reoperation rate due to recurrent abscess 52% (11/21) 73% (14/19)
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significant differences in healing rates nor differences in
postoperative continence status [11,12]. Moreover, the
addition of local antibiotics did not improve the out-
come [13].
Based on the course of the fistula, all complex fistula
including transsphincteric, suprasphincteric, and high
intersphincteric fistulas not amenable for fistulotomy are
potential indications for a flap repair. It is a prerequisite
that perianal sepsis has been eradicated previously (e.g.
excision of abscess with seton drainage of corresponding
fistula). From the technical aspect, fistulectomy with
removal of all fistula tracts may be a crucial factor, and
a sufficient external wound is mandatory.
The key question of surgery for complex anal fistulas
is whether factors predictive of success or failure can be
identified. Based on the literature, undrained perianal
sepsis, recurrent fistula, Crohn’s disease, rectovaginal fis-
tula, smoking, and previous radiation therapy have been
shown to deteriorate outcome [14-19].
In the 90ies, Schouten and colleagues demonstrated
clearly that the success rate was inversely correlated
with the number of prior attempts to close the fistula
[14]: Transrectal advancement flap repair for trans-
sphincteric fistula showed a success rate of 75% in total;
however, if flap repair was related to the number of
prior attempts, the authors indicated a 87% success rate
(no or only one previous repair) versus a 50% success
rate (two or more previous attempts) [14]. Additionally,
a high success rate of 75% for the whole collective was
combined with a 35% rate of deterioration of continence
status [14].
Mizrahi and colleagues reported a success rate of
59.6% (after a mean follow-up of 40 months) after flap
repair for both cryptoglandular and Crohn’sa s s o c i a t e d
fistulas [15]. Conversely, prior attempts to close the fis-
tula did not negatively influence outcome [15]. As
expected, a significantly higher recurrence rate (57.1%)
was observed after flap repair for complex fistulas asso-
ciated with Crohn’s disease when compared to fistulas
without Crohn’s disease (33.3%) [15].
Ellis demonstrated that the risk of failure was asso-
ciated with a history of previous attempts of fistula
repair and tobacco smoking [16].
A Dutch series with extended follow-up (median fol-
low-up 76 months) published by van Koperen and col-
leagues identified risk factors for recurrence after
advancement flap repair: However, they did not find any
- neither prior fistula surgery, smoking nor fibrin glue
[17].
An Austrian group assessed the influence of the type
of flap repair. They compared classical advancement flap
with mucosal flap in a series of 54 patients with high
transsphincteric fistula. They clearly demonstrated that
the advancement flap representing a full-thickness flap
was associated with a highly significant better outcome
without any negative impact on continence [18].
Moreover, the study of Mitalas and colleagues
impressively showed that the flap is repeatable. Report-
ing on 87 rectal advancement flap procedures, the pri-
mary healing rate was 67%. In these patients who had
primary failure and underwent “repeat flap”, the healing
rate was 69%. Altogether, a 90% overall healing rate
could be achieved without any negative impact on conti-
nence [19].
Summarizing the majority of available studies, it
becomes obvious that the management of complex fistu-
las is challenging, that clear conclusions based on these
studies cannot be drawn, and, that many gaps related to
primary failure or recurrence still remain.
At present, obesity is one of the most challenging
health problem in industrialized states with tremendous
impact on health systems and financial ressources. Obe-
sity is known to predispose for numerous health disor-
ders, and has been shown to be one of the most
important risk factor predictive of the development of
metabolic, endocrine and cardiovascular pathologies
such as diabetes, hypertension and coronary heart dis-
ease. Moreover, health consequences and co-morbidities
of obesity may negatively influence quality of life and
life-expectancy itself. As it has been proven that obese
patients have a higher incidence of comorbid conditions,
it has been proposed that these patients are at higher
risk of morbidity (e.g. wound infections, cardiopulmon-
ary complications) after surgery. Based on these con-
cepts, obese patients are generally believed to be at a
higher risk for surgery than those patients who are not
obese, although evidence-based convincing data are
lacking. Consequently, a variety of studies specifically
focussed on the impact of obesity on surgical outcomes.
However, there are no data available focussing on the
role of obesity on success or failure rates in surgery for
complex anal fistulas.
The current results indicate that obese patients suffer-
ing from complex anal fistulas had a worse outcome
related to success. Moreover, obesity was identified as
independent predictive factor for failure - and this was
not related to a higher incidence of co-morbidities such
as diabetes in obese patients. Additionally, reoperation
rate with the need for seton drainage due to recurrent
perianal abscess was significantly higher when compared
to non-obese patients. It can only be speculated which
reasons were associated with these findings. It can be
stated that the prevalence of co-morbidities was signifi-
cantly increased in obese patients when compared to
non-obese patients. Potentially, the local wound healing
of the flap was compromized in this subgroup of obese
patients. This would be in accordance to the role of
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smoking was associated with a higher risk for fistula
recurrence after advancement flap repair [20]. Another
reason could be that local hypoperfusion in fat tissue
negatively influences local wound healing. However, a
generally accepted cause for the presented results can-
not be provided and reasons remain speculative. Cer-
tainly, one has to admit that the study has some
limitations including a short follow-up period, a poten-
tial reporting bias, and no evaluation of continence data.
Conclusion
Obese patients are at higher risk to develop failure or
recurrence after surgery for complex anal fistulas.
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